| PRECLINICAL | evidence | Growth hormone in the aging male. | Tesamorelin | Growth hormone axis | 2013-08-01 |
| PRECLINICAL | evidence | Impact of Tesamorelin, a Growth Hormone-Releasing Factor (GRF) Analogue, on the Pharmacokinetics of Simvastatin and Ritonavir in Healthy Volunteers. | Tesamorelin | — | 2013-07-01 |
| PRECLINICAL | evidence | Pathophysiology of GHRH-growth hormone-IGF1 axis in HIV/AIDS. | Tesamorelin | Growth hormone axis | 2013-06-01 |
| PRECLINICAL | evidence | Neuroendocrinology: Tesamorelin can improve cognitive function. | Tesamorelin | — | 2012-10-01 |
| PRECLINICAL | evidence | New drugs 2012, part 2. | Tesamorelin | Growth hormone axis | 2012-07-01 |
| PRECLINICAL | evidence | How to diagnose a lipodystrophy syndrome. | Tesamorelin | Weight & fat loss | 2012-06-01 |
| PRECLINICAL | evidence | Pathogenesis and treatment of human immunodeficiency virus lipodystrophy. | Tesamorelin | — | 2012-03-01 |
| PRECLINICAL | evidence | Tesamorelin: a growth hormone-releasing factor analogue for HIV-associated lipodystrophy. | TH9507 | — | 2012-02-01 |
| PRECLINICAL | evidence | Tesamorelin. | Tesamorelin | — | 2012-01-01 |
| PRECLINICAL | evidence | Spotlight on tesamorelin in HIV-associated lipodystrophy. | Egrifta | — | 2011-12-01 |
| PRECLINICAL | evidence | The COPD Pipeline XIII. | Tesamorelin | — | 2011-12-01 |
| PRECLINICAL | evidence | Growth hormone axis treatments for HIV-associated lipodystrophy: a systematic review of placebo-controlled trials. | Tesamorelin | Weight & fat loss · n = 1511 | 2011-09-01 |
| PRECLINICAL | evidence | Tesamorelin: a novel therapeutic option for HIV/HAART-associated increased visceral adipose tissue. | Tesamorelin | Growth hormone axis | 2011-06-01 |
| PRECLINICAL | evidence | Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy. | Egrifta | — | 2011-05-28 |
| PRECLINICAL | evidence | Tesamorelin: A hope for ART-induced lipodystrophy. | Tesamorelin | — | 2011-04-01 |
| PRECLINICAL | evidence | Pathogenesis and treatment of HIV lipohypertrophy. | Tesamorelin | — | 2011-02-01 |
| PRECLINICAL | evidence | Tesamorelin. | Egrifta | — | 2011-02-01 |
| PRECLINICAL | evidence | Recent FDA approvals and changes. | Tesamorelin | — | 2011-02-01 |
| PRECLINICAL | evidence | Growth hormone and tesamorelin in the management of HIV-associated lipodystrophy. | Tesamorelin | — | 2011-01-01 |
| PRECLINICAL | evidence | Effects of a growth hormone-releasing hormone analog on endogenous GH pulsatility and insulin sensitivity in healthy men. | Tesamorelin | Growth hormone axis | 2011-01-01 |
| PRECLINICAL | evidence | Tesamorelin for the treatment of excess abdominal fat in HIV-1-infected patients with lipodystrophy. | Tesamorelin | — | 2011-01-01 |
| PRECLINICAL | evidence | FDA approves tesamorelin for HIV-related lipodystrophy. | Tesamorelin | — | 2010-12-15 |
| PRECLINICAL | evidence | Growth hormone-releasing factor agonists for the treatment of HIV-associated lipodystrophy. | Tesamorelin | Growth hormone axis | 2010-10-01 |
| PRECLINICAL | evidence | The power of advocacy. A first-hand account of how testimony helped win an FDA panel's approval of a new drug. | Tesamorelin | Growth hormone axis | 2010-07-01 |
| PRECLINICAL | evidence | HIV treatment information. | Tesamorelin | — | 2010-02-01 |
| PRECLINICAL | evidence | Epidemiology, assessment, and management of excess abdominal fat in persons with HIV infection. | Tesamorelin | Weight & fat loss | 2010-01-01 |
| PRECLINICAL | evidence | Tesamorelin update. | Tesamorelin | — | 2010-01-01 |
| PRECLINICAL | evidence | Tesamorelin, a human growth hormone releasing factor analogue. | Tesamorelin | Growth hormone axis | 2009-03-01 |
| PRECLINICAL | evidence | A 39-year-old man with HIV-associated lipodystrophy. | Tesamorelin | — | 2008-09-03 |
| PRECLINICAL | evidence | The next generation of human growth hormone. How Serostim and tesamorelin measure up. | Tesamorelin | Growth hormone axis | 2008-09-01 |
| PRECLINICAL | evidence | Approach to the human immunodeficiency virus-infected patient with lipodystrophy. | Tesamorelin | — | 2008-08-01 |
| PRECLINICAL | evidence | Tesamorelin for fat accumulation. 52-week effects and safety of tesamorelin (growth hormone releasing factor) in HIV patients with fat accumulation. | Tesamorelin | — | 2008-05-01 |
| PRECLINICAL | evidence | Effects of growth hormone-releasing factor in HIV-infected patients. | Tesamorelin | — | 2008-02-28 |
| PRECLINICAL | evidence | Recent highlights in clinical AIDS research. | Tesamorelin | — | 2008-02-01 |
| PRECLINICAL | evidence | Manipulation of the growth hormone axis in patients with HIV infection. | Tesamorelin | — | 2007-12-06 |
| PRECLINICAL | evidence | 14th annual retrovirus conference (CROI). Conference round-up. New lipo drug, rapid testing, and more news from CROI. | Tesamorelin | — | 2007-05-01 |
| PRECLINICAL | evidence | New lipodystrophy drug. | Tesamorelin | — | 2007-04-01 |
| PRECLINICAL | evidence | Side effects and complications. Stimulating growth hormone. | Tesamorelin | Growth hormone axis | 2007-03-01 |
| PRECLINICAL | evidence | Side effects and complications. Clinical trials of tesamorelin in Canada. | Tesamorelin | — | 2007-03-01 |
| PRECLINICAL | evidence | Side effects and complications. Tesamorelin--results from Phase III. | Tesamorelin | Growth hormone axis | 2007-03-01 |
| PRECLINICAL | evidence | Good results for lipodystrophy drug. | Tesamorelin | Weight & fat loss | 2007-02-01 |
| PRECLINICAL | evidence | TH9507: an experimental treatment for lipodystrophy. | TH9507 | — | 2007-01-01 |
| PRECLINICAL | evidence | Drug evaluation: tesamorelin, a synthetic human growth hormone releasing factor. | Tesamorelin | — | 2006-10-01 |
| PRECLINICAL | evidence | Gateways to clinical trials. | TH 9507 | — | 2005-12-01 |
| PRECLINICAL | evidence | Complications & side effects. Can TH9057 reduce fat deposits? | Tesamorelin | Growth hormone axis | 2004-11-01 |
| PRECLINICAL | evidence | Gateways to clinical trials. | TH 9507 | Lipid & cardiovascular markers | 2004-09-01 |
| PRECLINICAL | evidence | Peptide may help with fat accumulation. | Tesamorelin | — | 2003-09-01 |
| INDEPENDENT-REVIEW | review | Tesamorelin Lumps that last for days?
So I've been pinning Tesamorelin for a few weeks now, But I get this Lumps that itch, I have read her rthar it's normal but most people day it goes away in a few hours, Well mine doesn't, the lumps stay for a few days, like 2-4 days, should I discontinue? | COMMUNITY | — | 2026-07-27 |
| INDEPENDENT-REVIEW | review | Tesamorelin to cjc cycle? | COMMUNITY | — | 2026-07-24 |
| INDEPENDENT-REVIEW | review | Should you aim to be in a calorie deficit while on tesamorelin?
[removed] | COMMUNITY | — | 2026-07-22 |